Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Arabidopsis MTM2 Links SEC23A, ERES, and Autophagy
2026-08-07
This Arabidopsis study identifies Myotubularin 2 (MTM2) as a phosphatidylinositol 3-phosphate phosphatase at ER exit sites that restrains autophagy. By connecting PtdIns3P turnover with SEC23A-dependent COPII function, the work provides a mechanistic framework for understanding how secretory membranes and autophagosome formation are coordinated during starvation and salt stress.
-
Baicalin and KEAP1-NRF2/HO-1 Pathway Modulation in Research
2026-08-07
Baicalin, a flavone glycoside from Scutellaria baicalensis, delivers unique pathway modulation and neuroplasticity benefits for disease modeling and translational neuroscience. This article guides researchers through its use in advanced protocols, troubleshooting, and the latest evidence on restoring adult visual cortex plasticity.
-
AM251: CB1 Receptor Antagonist for Advanced Cannabinoid Rese
2026-08-06
AM251 empowers researchers to dissect CB1 receptor pathways with nanomolar precision—enabling breakthroughs in pain, metabolism, and neuropharmacology. Its selective antagonism and versatility in both in vitro and in vivo models make it an indispensable asset for translational cannabinoid receptor research.
-
BX795: Selective PDK1 Inhibitor for Cancer and Immune Resear
2026-08-06
BX795 is a nanomolar potency PDK1 inhibitor that also targets TBK1 and IKKε, enabling precise modulation of the PI3K/Akt/mTOR pathway and innate immune signaling. This dossier details its mechanism, benchmark data, and practical considerations for reproducible assay integration.
-
Applied Workflows with Dovitinib (TKI-258): RTK Inhibition U
2026-08-05
Dovitinib (TKI-258) empowers researchers to dissect RTK-driven signaling and apoptosis induction in complex cancer models. This article delivers stepwise protocols, troubleshooting strategies, and cross-model insights, with a focus on maximizing translational impact using APExBIO's high-quality compound.
-
MVC Exploits RhoA/ROCK1/MLC2 Pathway for Tight Junction Disr
2026-08-05
This study demonstrates that the Minute Virus of Canines (MVC) manipulates the RhoA/ROCK1/MLC2 signaling pathway to disrupt host cell tight junctions, exposing occludin and facilitating viral entry. The findings reveal a direct interaction between the MVC VP2 protein and ROCK1, offering new molecular targets for anti-MVC strategies and advancing our understanding of viral pathogenesis in canine models.
-
Screening MMV Compounds Against MDR Bacterial and Fungal Pat
2026-08-04
This study systematically screened Pandemic Response Box compounds against multidrug-resistant (MDR) clinical isolates of Acinetobacter baumannii, Pseudomonas aeruginosa, Candida auris, and Candida albicans. The findings highlight several candidate molecules with potent activity against drug-resistant fungi and bacteria, emphasizing the ongoing need for novel antimicrobial development.
-
PA-824: Bicyclic Nitroimidazole Derivative for TB Research S
2026-08-04
PA-824 accelerates tuberculosis research with robust, dual-action efficacy against both drug-sensitive and drug-resistant Mycobacterium tuberculosis. Explore advanced workflows, protocol enhancements, and troubleshooting strategies that maximize experimental reproducibility and translational impact.
-
Syringin Sensitizes RCC to Sunitinib via EGFR/PI3K/Akt Inhib
2026-08-03
This study demonstrates that Syringin, a natural product, inhibits renal cell carcinoma (RCC) cell growth and enhances sensitivity to sunitinib by targeting the EGFR/PI3K/Akt pathway. The findings provide a mechanistic rationale for using Syringin to overcome drug resistance in RCC and inform the design of combination treatment regimens.
-
Practical Use of HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L)
2026-08-03
The HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody enables sensitive, specific fluorescent detection of rabbit primary antibodies in immunofluorescence, microscopy, and flow cytometry. It should be avoided in protocols that require detection of non-rabbit primaries, direct conjugation to other labels, or are incompatible with sodium azide.
-
Olsalazine Sodium: Molecular Insights and Advanced Research
2026-08-02
Discover the multifaceted role of Olsalazine Sodium as a mesalamine dimer in inflammation and cancer research. This article offers a deep dive into its molecular mechanisms, unique transport dynamics, and how new findings can refine experimental assays.
-
Perphenazine in Translational Research: Mechanisms and New F
2026-08-01
Explore Perphenazine’s emerging roles in neuropharmacology and host-pathogen research, from dopamine D2 antagonism to mitochondria-mediated cell death and macrophage immune modulation. This thought-leadership article synthesizes mechanistic insights, recent evidence, and actionable strategies for translational researchers, highlighting APExBIO’s high-purity Perphenazine as a versatile tool for advanced workflows.
-
Bifendate (DDB): Multiomics Insights and Practical Hepatopro
2026-07-31
Discover how Bifendate (DDB) acts as a powerful hepatoprotective agent through multiomics-driven insights and unique regulatory pathways. This article reveals how advanced molecular profiling elevates DDB's application in liver research, offering a fresh perspective beyond standard protocol guides.
-
L-Glutathione Reduced: Precision Redox Modulation in Cancer
2026-07-31
L-Glutathione Reduced from APExBIO empowers researchers to dissect redox balance and metabolic vulnerabilities in cancer cells, with particular strength in oxidative stress and GST-affinity applications. This article delivers actionable workflows, protocol enhancements, and troubleshooting strategies tailored for high-impact translational research.
-
Lambda Protein Phosphatase: Precision Tools for Phosphorylat
2026-07-30
Lambda Protein Phosphatase (RNase-free) from APExBIO stands out as a dual-specificity enzyme for dissecting protein phosphorylation, excelling in workflows that demand validation of phospho-specific antibodies and site-specific dephosphorylation. Its robust performance and protocol versatility make it an indispensable tool for researchers interrogating post-translational regulation in circadian biology and beyond.